{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T13:40:05Z","timestamp":1745761205180,"version":"3.40.4"},"reference-count":19,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,8,12]]},"abstract":"<jats:p>This case describes an 81-year-old woman with a history of Sj\u00f6gren\u2019s syndrome presenting with recurrent falls and poor balance. She subsequently developed new and rapidly evolving neurology including hyperaesthesia, spastic paraplegia and sphincteric dysfunction. Following serial clinical reviews and detailed investigations, MRI (brainstem and cervicothoracic spine) and a seropositive result for aquaporin 4 IgG, a diagnosis of neuromyelitis optica spectrum disorder (NMOSD) was made. This case describes the clinical course of this index patient with an unusual late age of onset. The report also includes a discussion on NMOSD. We review aspects of terminology, brief epidemiology, pathogenesis, notable autoimmune associations, variance in clinical presentation and current diagnostic criteria. We also review the importance of distinguishing NMOSD from multiple sclerosis in view of the significant implications for treatment and prognosis.<\/jats:p>","DOI":"10.1136\/bcr-2018-225601","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T09:34:34Z","timestamp":1536399274000},"page":"bcr-2018-225601","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Neuromyelitis optica spectrum disorder presenting in an octogenarian"],"prefix":"10.1136","volume":"2018","author":[{"given":"Amy","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olayinka Ayodele","family":"Ogundipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,9,8]]},"reference":[{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312601"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.72"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.3","first-page":"99","article-title":"Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays","volume":"15","author":"Waters","year":"2008","journal-title":"Int MS J"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis spectrum disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"1-2","key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2015.05.034","article-title":"Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: a review","volume":"355","author":"Pereira","year":"2015","journal-title":"J Neurol Sci"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.7","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.314"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182190f74"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.9","first-page":"11","article-title":"Neuromyelitis optica spectrum disorder","volume":"17","author":"Broadley","year":"2017","journal-title":"ACNR"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.10","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2147\/NDT.S147360","article-title":"Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations","volume":"13","author":"Han","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001145","article-title":"The clinical characteristics of primary sjogren\u2019s syndrome with neuromyelitis optica spectrum disorder in China: a STROBE-Compliant Article","volume":"94","author":"Qiao","year":"2015","journal-title":"Medicine"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11926-016-0599-3","article-title":"(Devic\u2019s Syndrome): an Appraisal","volume":"18","author":"Crout","year":"2016","journal-title":"Current Rheumatology Reports"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001367"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.12794","article-title":"Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later","volume":"1366","author":"Pittock","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.15","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0400-8"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.16","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000049912.02954.2C"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.17","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2007.26"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.18","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws109"},{"key":"2025042706113264000_2018.sep07_1.bcr-2018-225601.19","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513515085"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-225601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T13:11:37Z","timestamp":1745759497000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-225601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,8]]},"references-count":19,"alternative-id":["10.1136\/bcr-2018-225601"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-225601","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,9,8]]}}}